13.07
price up icon1.55%   0.20
after-market アフターアワーズ: 13.09 0.02 +0.15%
loading

Replimune Group Inc (REPL) 最新ニュース

pulisher
Sep 12, 2026

REPL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 12, 2026
pulisher
Sep 12, 2026

REPL Stock Tracks Best Day Ever: This Analyst Sees Higher Approval Odds For Replimune’s Melanoma After ‘Overwhelmingly Positive’ Panel Outcome - Stocktwits

Sep 12, 2026
pulisher
Sep 12, 2026

REPL Stock Lost 19% Of Its Value Today – Why Did The FDA Refuse Approval For Its Experimental Melanoma Drug? - Stocktwits

Sep 12, 2026
pulisher
Sep 11, 2026

REPL Stock DropRobbins LLP Reminds Investors They May Be - GlobeNewswire

Sep 11, 2026
pulisher
Sep 11, 2026

Bragar Eagel & Squire, P.C. Announces that a Class Action - GlobeNewswire

Sep 11, 2026
pulisher
Sep 11, 2026

REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class ActionContact Levi & Korsinsky - Business Wire

Sep 11, 2026
pulisher
Sep 10, 2026

REPL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 10, 2026
pulisher
Sep 10, 2026

Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, - GlobeNewswire

Sep 10, 2026
pulisher
Sep 10, 2026

REPL: TUDRIQEV launch targets rapid adoption in key accounts, with expansion and new indications ahead - TradingView

Sep 10, 2026
pulisher
Sep 10, 2026

DEADLINE ALERT for REPL, DVLT, and UWMC: The Law Offices of - GlobeNewswire

Sep 10, 2026
pulisher
Sep 10, 2026

Replimune faces class action over alleged nondi... - Pluang

Sep 10, 2026
pulisher
Sep 10, 2026

Replimune at cantor healthcare conference: careful launch, broad pipeline By Investing.com - Investing.com Canada

Sep 10, 2026
pulisher
Sep 10, 2026

REPL Investor Alert: Replimune Group, Inc. Securities Class Action NoticeContact SueWallSt - PR Newswire

Sep 10, 2026
pulisher
Sep 09, 2026

Class action lawsuit filed against Replimune fo... - Pluang

Sep 09, 2026
pulisher
Sep 09, 2026

Replimune faces securities lawsuit over alleged misleading FDA trial data claims, stock plunged 84%. - Pluang

Sep 09, 2026
pulisher
Sep 09, 2026

REPL Deadline Alert: Levi & Korsinsky Reminds Replimune Group, Inc. (REPL) Investors of Securities Class Action Deadline on October 5, 2026 - PR Newswire

Sep 09, 2026
pulisher
Sep 09, 2026

Replimune Group Stock Short Interest Falls to 43.08% - moomoo.com

Sep 09, 2026
pulisher
Sep 08, 2026

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire

Sep 08, 2026
pulisher
Sep 07, 2026

REPL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Sep 07, 2026
pulisher
Sep 07, 2026

REPL Stock On Track To Hit All-Time Lows – Here’s Why This Analyst Slashed Price Target By 85% - Stocktwits

Sep 07, 2026
pulisher
Sep 07, 2026

Price to earnings forward of Replimune Group, Inc. – NASDAQ:REPL - TradingView

Sep 07, 2026
pulisher
Sep 06, 2026

2026-09-06 | REPL SHAREHOLDER ALERT - Stockhouse

Sep 06, 2026
pulisher
Sep 06, 2026

Avoiding Lag: Real-Time Signals in (REPL) Movement - Stock Traders Daily

Sep 06, 2026
pulisher
Sep 04, 2026

REPL Stock Soars on Plans of BLA Resubmission for Melanoma Combo Drug - Eastern Progress

Sep 04, 2026
pulisher
Sep 03, 2026

Replimune shares plunge 84% after FDA rejects R... - Pluang

Sep 03, 2026
pulisher
Sep 03, 2026

Deadline Alert: Replimune Group, Inc. (REPL) Shareholders - GlobeNewswire

Sep 03, 2026
pulisher
Sep 03, 2026

Replimune investors urged to seek lead plaintiff role by Oct 5 deadline - scanx.trade

Sep 03, 2026
pulisher
Sep 03, 2026

Class action lawsuit filed against Replimune af... - pluang.com

Sep 03, 2026
pulisher
Sep 03, 2026

REPL DEADLINE: SueWallSt Reminds Replimune Group, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire

Sep 03, 2026
pulisher
Sep 03, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming DeadlinesREPL - PR Newswire

Sep 03, 2026
pulisher
Sep 03, 2026

Replimune to Present at the Cantor Global Healthcare Conference 2026 - The Manila Times

Sep 03, 2026
pulisher
Sep 02, 2026

Robbins LLP Urges REPL Stockholders to Contact the Firm for Information About the Class Action Against Replimune Group, Inc. - Business Wire

Sep 02, 2026
pulisher
Sep 02, 2026

REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action LawsuitInvestors With Losses May Contact Levi & Korsinsky - Morningstar

Sep 02, 2026
pulisher
Sep 02, 2026

Replimune Group stock hits 52-week high at 16.2 USD By Investing.com - Investing.com Canada

Sep 02, 2026
pulisher
Sep 02, 2026

Replimune Group stock hits 52-week high at 16.2 USD - Investing.com

Sep 02, 2026
pulisher
Aug 31, 2026

REPL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Aug 31, 2026
pulisher
Aug 31, 2026

Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - WBOC TV

Aug 31, 2026
pulisher
Aug 31, 2026

Levi & Korsinsky Reminds Replimune Group, Inc. Investors of - GlobeNewswire

Aug 31, 2026
pulisher
Aug 27, 2026

REPL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Replimune Group, Inc. Securities LawsuitContact SueWallSt - PR Newswire

Aug 27, 2026
pulisher
Aug 26, 2026

Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today? - Yahoo Finance

Aug 26, 2026
pulisher
Aug 25, 2026

Replimune Group, Inc. (REPL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Aug 25, 2026
pulisher
Aug 25, 2026

Replimune Group stock hits 52-week high at 15.72 USD By Investing.com - Investing.com Nigeria

Aug 25, 2026
pulisher
Aug 24, 2026

REPL Deadline Alert: Levi & Korsinsky Reminds Replimune - GlobeNewswire

Aug 24, 2026
pulisher
Aug 22, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc.REPL - Eastern Progress

Aug 22, 2026
pulisher
Aug 21, 2026

Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop - TipRanks

Aug 21, 2026
pulisher
Aug 21, 2026

Robbins LLP Urges REPL Investors Who Lost Money Investing in Replimune to Contact the Firm for Information About Leading the Class Action - PR Newswire

Aug 21, 2026
pulisher
Aug 21, 2026

DEADLINE ALERT for BZAI, BABA, ALAR, and REPL: The Law - GlobeNewswire

Aug 21, 2026
pulisher
Aug 21, 2026

REPL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Aug 21, 2026
pulisher
Aug 20, 2026

Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today? - Stocktwits

Aug 20, 2026
pulisher
Aug 20, 2026

Replimune (REPL) Results at a Glance: Profit Per Share Falls Below Its Benchmark; Market Response: Shares Move Lower 3.31% in the Available RecordFinancial Summary - vinanet.vn

Aug 20, 2026
pulisher
Aug 20, 2026

REPL UPCOMING DEADLINE: SueWallSt Alerts Replimune Group, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire

Aug 20, 2026
pulisher
Aug 20, 2026

Replimune (REPL) Earnings Update: The Bottom-Line Figure Trails Its Comparison in the Latest Reading; Market Reaction: The Stock Ends Down 3.88% in the Latest ReadingDownward Estimate Revision - vinanet.vn

Aug 20, 2026
$58.41
price down icon 0.88%
$120.00
price down icon 3.21%
$39.77
price down icon 0.53%
$239.56
price down icon 2.42%
ONC ONC
$350.84
price down icon 0.74%
$190.95
price down icon 3.04%
大文字化:     |  ボリューム (24 時間):